Unlearn.AI
Harnessing data, AI, and digital twins to transform clinical development
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- unlearn.ai
- Total Funding
- $116.8M
- Last Round
- $50.0M Series CFeb 2024
- Rounds
- 5
About
Unlearn.AI harnesses data, AI, and digital twins to transform clinical development. Their TwinRCT technology creates AI-generated digital twins of trial participants, enabling smaller, more robust randomized controlled trials that bring life-saving treatments to patients faster. Partnered with leading pharma companies globally.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Feb 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...